ABBOTT INDIA LIMITED
- Country
- 🇮🇳India
- Ownership
- Private
- Established
- 1888-01-01
- Employees
- 73K
- Market Cap
- $7.5B
- Website
- http://www.abbott.com
To Evaluate the Safety of Veliparib in Combination With Temozolomide in Subjects With Solid Tumors
- First Posted Date
- 2010-09-01
- Last Posted Date
- 2012-11-21
- Lead Sponsor
- Abbott
- Target Recruit Count
- 24
- Registration Number
- NCT01193140
- Locations
- 🇺🇸
Site Reference ID/Investigator# 42662, Santa Monica, California, United States
🇺🇸Site Reference ID/Investigator# 43022, Encinitas, California, United States
Compare Pharmaceutical Economics and Efficacy of Sevoflurane With Low Fresh Gas Flow Balanced Anesthesia, Propofol Target Controlled Infusion Anesthesia and Propofol Induction Sevoflurane Maintenance Anesthesia
- First Posted Date
- 2010-08-30
- Last Posted Date
- 2012-07-03
- Lead Sponsor
- Abbott
- Target Recruit Count
- 336
- Registration Number
- NCT01191476
- Locations
- 🇨🇳
Site Reference ID/Investigator# 41983, Beijing, China
🇨🇳Site Reference ID/Investigator# 41932, Chengdu, China
🇨🇳Site Reference ID/Investigator# 41984, Shanghai, China
Study of ABT-267 in Both Healthy Volunteers and Hepatitis C Virus (HCV) Genotype 1 Infected Subjects
- Conditions
- Interventions
- First Posted Date
- 2010-08-13
- Last Posted Date
- 2012-01-24
- Lead Sponsor
- Abbott
- Target Recruit Count
- 137
- Registration Number
- NCT01181427
- Locations
- 🇺🇸
Site Reference ID/Investigator# 43322, Waukegan, Illinois, United States
🇺🇸Site Reference ID/Investigator# 42707, San Antonio, Texas, United States
🇺🇸Site Reference ID/Investigator# 42708, Orlando, Florida, United States
Study to Characterize Demographics, Compliance, Tolerability and Safety in Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis Prescribed Adalimumab (Humira®) as Part of Routine Clinical Care
- Conditions
- First Posted Date
- 2010-07-16
- Last Posted Date
- 2012-12-07
- Lead Sponsor
- Abbott
- Target Recruit Count
- 252
- Registration Number
- NCT01163916
- Locations
- 🇷🇺
Site Ref # / Investigator 50731, Izhevsk, Russian Federation
🇷🇺Site Reference ID/Investigator# 29482, Moscow, Russian Federation
🇷🇺Site Reference ID/Investigator# 29195, Moscow, Russian Federation
Long-term Effectiveness and Safety in Hepatitis-co-infected Patients
- Conditions
- Interventions
- First Posted Date
- 2010-06-30
- Last Posted Date
- 2011-12-19
- Lead Sponsor
- Abbott
- Target Recruit Count
- 33
- Registration Number
- NCT01153269
- Locations
- 🇩🇪
Site Reference ID/Investigator# 27587, Frankfurt, Germany
🇩🇪Site Reference ID/Investigator# 27607, Hamburg, Germany
🇩🇪Site Reference ID/Investigator# 27575, Berlin, Germany
Time to DMARD (Disease-Modifying Anti-Rheumatic Drug) Treatment and Actual Work Limitation of Patients With Rheumatoid Arthritis in Turkey
- Conditions
- First Posted Date
- 2010-06-15
- Last Posted Date
- 2012-10-02
- Lead Sponsor
- Abbott
- Target Recruit Count
- 356
- Registration Number
- NCT01144598
- Locations
- 🇹🇷
Site Reference ID/Investigator# 39108, Izmir, Turkey
🇹🇷Site Reference ID/Investigator# 39111, Adana, Turkey
🇹🇷Site Reference ID/Investigator# 39104, Ankara, Turkey
ESPRIT Study in Hypogonadal Men
- First Posted Date
- 2010-06-14
- Last Posted Date
- 2011-10-17
- Lead Sponsor
- Abbott
- Target Recruit Count
- 1053
- Registration Number
- NCT01143818
- Locations
- 🇸🇦
Site Ref # / Investigator 59424, Hofouf, Saudi Arabia
🇸🇦Site Ref # / Investigator 59393, Makka, Saudi Arabia
🇸🇦Site Ref # / Investigator 59403, Makka, Saudi Arabia
This is a Single Ascending Dose Tolerance Study
- Conditions
- Interventions
- First Posted Date
- 2010-05-31
- Last Posted Date
- 2011-08-29
- Lead Sponsor
- Abbott
- Target Recruit Count
- 47
- Registration Number
- NCT01133574
- Locations
- 🇬🇧
Site Reference ID/Investigator# 62002, London, United Kingdom
Evaluation of Effectiveness of the Treatment After Repeated Administration of Klacid®SR
- First Posted Date
- 2010-05-26
- Last Posted Date
- 2011-09-12
- Lead Sponsor
- Abbott
- Target Recruit Count
- 3130
- Registration Number
- NCT01130883
- Locations
- 🇨🇿
Site Reference ID/Investigator# 37381, Bilina, Czech Republic
🇨🇿Site Reference ID/Investigator# 37282, Blansko, Czech Republic
🇨🇿Site Reference ID/Investigator# 37424, Boskovice, Czech Republic
A Study of Effectiveness and Safety of Tumor Necrosis Factor (TNF) Inhibitors in Patients With Moderate to Severe Psoriasis
- Conditions
- First Posted Date
- 2010-05-20
- Last Posted Date
- 2012-10-25
- Lead Sponsor
- Abbott
- Target Recruit Count
- 103
- Registration Number
- NCT01126619
- Locations
- 🇹🇷
Site Reference ID/Investigator# 44102, Kirikkale, Turkey
🇹🇷Site Reference ID/Investigator# 44105, Zonguldak, Turkey
🇹🇷Site Reference ID/Investigator# 38773, Malatya, Turkey